Carcinoma types
Pro Research Analysisby 
Searched over 200M research papers for "carcinoma types"
Consensus Meter
Overview of Carcinoma Types
Carcinomas are a diverse group of cancers originating from epithelial cells. They are classified based on their histopathological and molecular characteristics, which influence their behavior, treatment, and prognosis. This article provides an overview of various carcinoma types, focusing on ovarian, renal, gastric, and lung carcinomas.
Ovarian Carcinomas: Distinct Subtypes
High-Grade and Low-Grade Serous Carcinomas
Ovarian carcinomas are primarily divided into five main types: high-grade serous (70%), endometrioid (10%), clear cell (10%), mucinous (3%), and low-grade serous (<5%) carcinomas . High-grade serous carcinomas (HGSCs) are characterized by TP53 mutations and often originate from the fallopian tube epithelium . In contrast, low-grade serous carcinomas (LGSCs) typically arise from serous borderline tumors and exhibit mutations in KRAS or BRAF genes .
Endometrioid and Clear Cell Carcinomas
Endometrioid and clear cell carcinomas often originate from ovarian endometriosis. Endometrioid carcinomas share some molecular features with their uterine counterparts but have lower rates of microsatellite instability and PTEN alterations. Clear cell carcinomas frequently exhibit ARID1A and PIK3CA mutations .
Mucinous Carcinomas
Mucinous carcinomas are less common and usually present as unilateral, stage I tumors. They often progress from mucinous cystadenomas and exhibit KRAS mutations and HER2 overexpression .
Renal Cell Carcinoma (RCC): Immunogenic Tumor
Renal cell carcinoma (RCC) is the most common type of kidney cancer, with clear-cell RCC being the predominant subtype (~70%). RCC is known for its immunogenic properties, often involving immune-inhibitory cells like regulatory T cells and myeloid-derived suppressor cells, which suppress effective anti-tumor immune responses. Immune checkpoint inhibitors have shown promise in treating RCC, although not all patients respond favorably, highlighting the need for reliable biomarkers and novel therapeutic strategies.
Gastric Carcinoma: Expanding and Infiltrative Types
Gastric carcinomas are classified into two main types based on their growth patterns: expanding and infiltrative. Expanding carcinomas grow en masse, forming discrete tumor nodules, while infiltrative carcinomas invade individually. These types differ in their histogenetic origins, with intestinal metaplasia playing a role in the development of expanding carcinomas but not infiltrative ones. The classification aids in understanding the tumor's behavior and guiding treatment strategies.
Lung Carcinosarcomas: Mixed Histology
Carcinosarcomas of the lung are rare tumors that contain both carcinoma and sarcoma elements, such as malignant cartilage, bone, and skeletal muscle. These tumors often present as solitary masses and have a poor prognosis, with a 5-year survival rate of 21.3%. The epithelial component is most frequently squamous cell carcinoma, followed by adenocarcinoma and adenosquamous carcinoma.
Conclusion
Carcinomas are a heterogeneous group of cancers with distinct histopathological and molecular features. Understanding these differences is crucial for accurate diagnosis, prognosis, and treatment. Advances in molecular pathology have significantly improved our knowledge of these cancers, paving the way for more targeted and effective therapies.
Sources and full results
Most relevant research papers on this topic